X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AJANTA PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AJANTA PHARMA ABBOTT INDIA/
AJANTA PHARMA
 
P/E (TTM) x 33.0 20.0 165.4% View Chart
P/BV x 8.2 8.6 95.5% View Chart
Dividend Yield % 0.8 0.7 117.1%  

Financials

 ABBOTT INDIA   AJANTA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
AJANTA PHARMA
Mar-16
ABBOTT INDIA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs6,0151,720 349.7%   
Low Rs3,7071,103 336.1%   
Sales per share (Unadj.) Rs1,236.9194.6 635.6%  
Earnings per share (Unadj.) Rs122.245.2 270.2%  
Cash flow per share (Unadj.) Rs129.050.3 256.4%  
Dividends per share (Unadj.) Rs35.008.00 437.5%  
Dividend yield (eoy) %0.70.6 127.0%  
Book value per share (Unadj.) Rs521.2132.0 394.8%  
Shares outstanding (eoy) m21.2588.77 23.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.97.3 54.2%   
Avg P/E ratio x39.831.2 127.5%  
P/CF ratio (eoy) x37.728.1 134.3%  
Price / Book Value ratio x9.310.7 87.2%  
Dividend payout %28.617.7 161.9%   
Avg Mkt Cap Rs m103,296125,299 82.4%   
No. of employees `0003.0NA-   
Total wages/salary Rs m3,3702,570 131.1%   
Avg. sales/employee Rs Th8,891.8NM-  
Avg. wages/employee Rs Th1,140.0NM-  
Avg. net profit/employee Rs Th878.3NM-  
INCOME DATA
Net Sales Rs m26,28417,275 152.1%  
Other income Rs m504166 303.3%   
Total revenues Rs m26,78917,442 153.6%   
Gross profit Rs m3,6655,807 63.1%  
Depreciation Rs m144451 32.0%   
Interest Rs m849 16.6%   
Profit before tax Rs m4,0175,474 73.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4211,460 97.3%   
Profit after tax Rs m2,5964,014 64.7%  
Gross profit margin %13.933.6 41.5%  
Effective tax rate %35.426.7 132.6%   
Net profit margin %9.923.2 42.5%  
BALANCE SHEET DATA
Current assets Rs m14,4467,639 189.1%   
Current liabilities Rs m4,7252,715 174.0%   
Net working cap to sales %37.028.5 129.8%  
Current ratio x3.12.8 108.7%  
Inventory Days Days5143 118.9%  
Debtors Days Days2079 24.9%  
Net fixed assets Rs m1,1136,914 16.1%   
Share capital Rs m213177 120.1%   
"Free" reserves Rs m10,80811,442 94.5%   
Net worth Rs m11,07611,721 94.5%   
Long term debt Rs m0149 0.0%   
Total assets Rs m16,24114,814 109.6%  
Interest coverage x497.0112.9 440.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.61.2 138.8%   
Return on assets %16.027.4 58.5%  
Return on equity %23.434.2 68.4%  
Return on capital %36.346.5 78.1%  
Exports to sales %0.655.1 1.1%   
Imports to sales %12.66.0 210.5%   
Exports (fob) Rs m1629,527 1.7%   
Imports (cif) Rs m3,3221,038 320.2%   
Fx inflow Rs m26810,422 2.6%   
Fx outflow Rs m3,9271,678 234.0%   
Net fx Rs m-3,6598,744 -41.9%   
CASH FLOW
From Operations Rs m2,5143,264 77.0%  
From Investments Rs m-800-2,093 38.2%  
From Financial Activity Rs m-803-1,186 67.7%  
Net Cashflow Rs m912-15 -6,161.5%  

Share Holding

Indian Promoters % 0.0 73.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 1.6 509.7%  
FIIs % 0.1 7.6 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.0 100.6%  
Shareholders   18,270 20,968 87.1%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   DR. DATSONS LABS  STRIDES SHASUN LTD  GLENMARK PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 22, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS